Understanding brain pathways affected by aging and Alzheimer's disease

Mapping the vulnerable locus coeruleus pathways in aging and AD

NIH-funded research Massachusetts Institute of Technology · NIH-10913512

This study looks at how aging and Alzheimer's disease affect certain brain pathways in mice, helping us understand why some parts of the brain are more likely to get damaged, which could lead to new ways to treat the disease.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionMassachusetts Institute of Technology NIH-funded
Lab location1 site (Cambridge, United States)
Project IDNIH-10913512 on NIH RePORTER

What this research studies

This research investigates how specific brain pathways, particularly those connected to the locus coeruleus, are impacted by aging and Alzheimer's disease (AD). By examining the connectivity and sensitivity of these pathways in both aging and AD model mice, the research aims to identify why certain brain regions are more vulnerable to degeneration. The study employs advanced techniques to analyze neuronal populations and their connections, providing insights into the mechanisms of AD progression. This could lead to a better understanding of the disease and potential targets for future therapies.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals experiencing cognitive decline or diagnosed with Alzheimer's disease, particularly those in the early stages.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's disease by targeting vulnerable brain pathways.

How similar studies have performed: Previous research has shown promise in understanding brain connectivity in Alzheimer's disease, suggesting that this approach could yield valuable insights.

Where this research is happening

Cambridge, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease model
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.